Phase 1/2a Clinical Trial to Evaluate Safety and Preliminary Efficacy of CRG-150 in Metastatic Triple-Negative Breast Cancer, HR+ HER2− Breast Cancer, and Prostate Cancer at Leading Academic Medical C ...
Houston biopharma company CoRegen said it has received US Food and Drug Administration clearance to begin a Phase I/II trial of CRG-150, an adoptive cell therapy targeting steroid receptor coactivator ...
Peptide may not yet be the 2026 Oxford Word of the Year, but it must surely be in the running. From your friendly ...
Medicare has expanded access to GLP-1 weight-loss medications. These drugs may also help treat addiction. Primary care ...
Years ago, LSD was seen as the evil stepchild of drugs. Today, research indicates LSD may treat anxiety and depression, and ...
The strain of the virus that's responsible for the current outbreak has no specific treatments or preventive measures. Three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results